Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Mar;27(3):381–390.

Purification and characterization of human liver-specific membrane lipoprotein (LSP).

I G McFarlane, B M Wojcicka, G M Zucker, A L Eddleston, R Williams
PMCID: PMC1540950  PMID: 862227

Abstract

A liver-specific lipoprotein (LSP) which is present in 105,000 g supernatants of human liver has previously been shown to produce a lesion resembling chronic active hepatitis in rabbits immunized with human liver fractions containing this lipoprotein. In addition, it has been implicated as the principal target antigen involved in the liver cell cytotoxicity exhibited in vitro by lymphocytes from patients with chronic active hepatitis. The organ-specificity and species cross-reactivity of LSP is confirmed. Although very labile, is has been prepared in a stable form by gel filtration of Sepharose 6B in a Tris buffer containing 1 mm disodium EDTA. LSP is also stable in a borate buffer containing EDTA but is unstable in a number of other buffer systems tested. When prepared by this method it contains approximately 2% albumin as the only detectable contaminant. Gel filtration studies on the apoprotein of LSP revealed that it has an apparent mol. wt of between 4 X 10(6) and 20 X 10(6). SDA-polyacrylamide gel electrophoresis indicated that the lipoprotein may be composed of up to thirteen sub-units of different molecular sizes.

Full text

PDF
381

Images in this article

384Fig. 3
on p.384
384Fig. 4
on p.384
386Fig. 6
on p.386
386Fig. 7
on p.386
388Fig. 11
on p.388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auer I. O., Milgrom F. Studies on thermostable liver-specific antigens. Int Arch Allergy Appl Immunol. 1972;42(6):871–884. doi: 10.1159/000230664. [DOI] [PubMed] [Google Scholar]
  2. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  3. Büschenfelde K. H., Kössling F. K., Miescher P. A. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin Exp Immunol. 1972 May;11(1):99–108. [PMC free article] [PubMed] [Google Scholar]
  4. Cochrane A. M., Moussouros A., Thomsom A. D., Eddleston A. L., Wiiliams R. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet. 1976 Feb 28;1(7957):441–444. doi: 10.1016/s0140-6736(76)91472-0. [DOI] [PubMed] [Google Scholar]
  5. D'AMELIO V., PERLMANN P. The distribution of soluble antigens in cellular structures of rat liver. Exp Cell Res. 1960 Mar;19:383–398. doi: 10.1016/0014-4827(60)90016-1. [DOI] [PubMed] [Google Scholar]
  6. Dumonde D. C. Tissue-specific antigens. Adv Immunol. 1966;5:245–412. doi: 10.1016/s0065-2776(08)60275-8. [DOI] [PubMed] [Google Scholar]
  7. Fravi G., Lindenmann J. Induction by allogeneic extracts of liver-specific precipitating autoantibodies in the mouse. Nature. 1968 Apr 13;218(5137):141–143. doi: 10.1038/218141a0. [DOI] [PubMed] [Google Scholar]
  8. Helenius A., Simons K. Removal of lipids from human plasma low-density lipoprotein by detergents. Biochemistry. 1971 Jun 22;10(13):2542–2547. doi: 10.1021/bi00789a019. [DOI] [PubMed] [Google Scholar]
  9. Hopf U., Meyer zum Büschenfelde K. H., Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med. 1976 Mar 11;294(11):578–582. doi: 10.1056/NEJM197603112941103. [DOI] [PubMed] [Google Scholar]
  10. Hopf U., Meyer zum Büschenfelde K. H., Freudenberg J. Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes. Clin Exp Immunol. 1974 Jan;16(1):117–123. [PMC free article] [PubMed] [Google Scholar]
  11. Hughes R. D., Cochrane A. M., Thomson A. D., Murray-Lyon I. M., Williams R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol. 1976 Jun;57(3):348–353. [PMC free article] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lenard J., Singer S. J. Succinylation of gamma globulin. Nature. 1966 Apr 30;210(5035):536–537. doi: 10.1038/210536a0. [DOI] [PubMed] [Google Scholar]
  14. Miller J., Smith M. G., Mitchell C. G., Reed W. D., Eddleston A. L., Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. doi: 10.1016/s0140-6736(72)92904-2. [DOI] [PubMed] [Google Scholar]
  15. PERLMANN P., D'AMELIO V. Soluble antigens in microsomes and other cell-fractions of rat liver. Nature. 1958 Feb 15;181(4607):491–492. doi: 10.1038/181491a0. [DOI] [PubMed] [Google Scholar]
  16. POULIK M. D. Starch gel electrophoresis in a discontinous system of buffers. Nature. 1957 Dec 28;180(4600):1477–1479. doi: 10.1038/1801477a0. [DOI] [PubMed] [Google Scholar]
  17. Reeve C. E. Chemical characteristics of microsomal liver specific antigens in the rat. Br J Cancer. 1967 Jun;21(2):401–410. doi: 10.1038/bjc.1967.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Smith M. G., Eddleston A. L., Williams R. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases. Clin Gastroenterol. 1975 May;4(2):297–313. [PubMed] [Google Scholar]
  19. Thomson A. D., Cochrane M. A., McFarlane I. G., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature. 1974 Dec 20;252(5485):721–722. doi: 10.1038/252721a0. [DOI] [PubMed] [Google Scholar]
  20. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES